These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 307740)

  • 21. [A new cause of torsades de pointes: combination of terfenadine and troleandomycin].
    Fournier P; Pacouret G; Charbonnier B
    Ann Cardiol Angeiol (Paris); 1993 May; 42(5):249-52. PubMed ID: 8368797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A combination of dihydroergotamine and acetylsalicylic acid--prevention of postoperative thromboembolic complications. Clinical study in orthopedics].
    Stern D; Vasey H
    Schweiz Med Wochenschr; 1987 Dec; 117(51):2084-8. PubMed ID: 3433091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Troleandomycin and methylprednisolone for treatment of the hypereosinophilic syndrome.
    Edwards D; Wald JA; Dobozin BS; Kirkpatrick CH
    N Engl J Med; 1987 Aug; 317(9):573-4. PubMed ID: 3497348
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study on triacetyloleandomycin in the prevention of rheumatic fever: its effects on hepatic function].
    Gilbert G; Tardif B; Lefebvre M; David P
    Laval Med; 1967 Dec; 38(10):911-4. PubMed ID: 5302265
    [No Abstract]   [Full Text] [Related]  

  • 25. [The problem of ergotism in thrombosis prevention with drugs].
    Räber G; Bauermeister U
    Z Arztl Fortbild (Jena); 1983; 77(23):965-8. PubMed ID: 6670300
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of thromboembolism with heparin and dihydroergotamine (DHE) in internal medicine--comparison of various administration forms of dihydroergotamine].
    Schott G; Kreibich U; Sommer S; Möckel G; Beitz R; Rothe G
    Z Arztl Fortbild (Jena); 1988; 82(11):509-11. PubMed ID: 3051706
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies of the hepatotoxicity of triacetyloleandomycin (TAO) in humans].
    Sasso C; Arpino E
    Minerva Med; 1969 May; 60(35):1689-94. PubMed ID: 5306225
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effective prevention of thromboembolism with heparin and dihydroergotamine].
    Adolf J; Buttermann G; Theisinger W
    Med Klin; 1981 Jul; 76(16):457-8. PubMed ID: 7266416
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic advances in thromboembolic disease. I. Dihydroergotamine + heparin].
    de Diego I; Jané F; Félez J
    Sangre (Barc); 1981; 26(4):471-83. PubMed ID: 7027494
    [No Abstract]   [Full Text] [Related]  

  • 30. Ergotism with therapeutic doses of ergotamine tartrate.
    Matthews NT; Havill JH
    N Z Med J; 1979 Jun; 89(638):476-7. PubMed ID: 314074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dihydroergotamine as a nasal spray in the therapy of migraine attacks. Efficacy and tolerance].
    Jenzer G; Bremgartner MF
    Schweiz Rundsch Med Prax; 1990 Aug; 79(31-32):914-7. PubMed ID: 2203127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precipitation of acute ergotism by triacetyloleandomycin.
    Hayton AC
    N Z Med J; 1969 Jan; 69(440):42. PubMed ID: 5304704
    [No Abstract]   [Full Text] [Related]  

  • 33. [Angiospasm and dihydroergotamine--dangers in thromboprevention].
    Schwering H; Rühland D
    Zentralbl Chir; 1985; 110(18):1115-21. PubMed ID: 4082802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Triacetyloleandomycin-induced toxic hepatitis].
    Shishido H; Furusawa S; Amakawa T; Yamaguchi Y; Nakagawa M
    Naika; 1965 Nov; 16(6):1176-8. PubMed ID: 5296328
    [No Abstract]   [Full Text] [Related]  

  • 35. What is known about the action of dihydroergotamine on the vasculature in man?
    Müller-Schweinitzer E
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):677-82. PubMed ID: 6396240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of migraine attacks through the use of dihydroergotamine.
    Neuman M; Demarez JP; Harmey JL; Le Bastard B; Cauquil J
    Int J Clin Pharmacol Res; 1986; 6(1):11-3. PubMed ID: 3514491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholestatic jaundice after triacetyloleandomycin and oral contraceptives. The diagnostic value of gamma-glutamyl transpeptidase.
    Haber I; Hubens H
    Acta Gastroenterol Belg; 1980; 43(11-12):475-82. PubMed ID: 6971036
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in general surgery].
    Schott G
    Z Gesamte Inn Med; 1984 Sep; 39(17):431-5. PubMed ID: 6506818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood and tissue levels of oleandomycin in man as consequence of administration by oral route of triacetyloleandomycin].
    Liani M; Porzio R; Porzio D
    Antibiotica; 1968 Dec; 6(4):368-74. PubMed ID: 5309023
    [No Abstract]   [Full Text] [Related]  

  • 40. [Circulatory insufficiency during prevention of thrombosis with heparin/dihydroergotamine. Effect or side-effect?].
    Borris LC; Lassen MR; Christiansen HM; Møller-Larsen F; Knudsen VE; Nielsen BW
    Ugeskr Laeger; 1988 Jul; 150(27):1682-3. PubMed ID: 3388590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.